Melatonin in the afternoons of a gradually advancing sleep schedule enhances the circadian rhythm phase advance.
Melatonin in the afternoons of a gradually advancing sleep schedule enhances the circadian rhythm phase advance.
复制标题
DOI:
10.1007/s00213-012-2869-8
复制
发表时间:
2013-02
影响因子:
3.4
通讯作者:
Eastman, Charmane I.
中科院分区:
文献类型:
--
作者:
Crowley, Stephanie J.;Eastman, Charmane I.
关键词:
We test methods to advance (shift earlier) circadian rhythms without producing misalignment between rhythms and sleep. We previously tested 1) a gradually advancing sleep/dark schedule plus morning bright light and afternoon/evening melatonin; and 2) the same sleep schedule with only morning bright light. Now we report on the same sleep schedule with only afternoon/evening melatonin. To examine phase advances, sleepiness and performance in response to melatonin compared to placebo. Twelve adults (5 female) aged 20–45 years (mean ± SD = 28.3 ± 7.3 years) completed this within-subjects placebo-controlled counterbalanced study. Participants slept on fixed 8-hour sleep schedules for 9 baseline days. Then, sleep/dark was advanced by 1 h/day for 3 consecutive days of treatment. Participants took 3 mg of melatonin or placebo 11 hours before baseline sleep midpoint (the optimal time to produce phase advances) on the first treatment day and 1 hour earlier each subsequent day. We measured the dim light melatonin onset (DLMO) before and after treatment. Participants rated subjective symptoms throughout the study. They completed the Psychomotor Vigilance Task (PVT) and rated sleepiness from 1 h before pill ingestion until bedtime each treatment day. Melatonin produced significantly larger advances (1.3 ± 0.7 h) compared to placebo (0.7 ± 0.7 h); however, in the hours between melatonin ingestion and bed, melatonin caused sleepiness and performance decrements. Adding afternoon/evening melatonin to the gradually advancing sleep schedule increased the phase advance, but given the side effects, like sleepiness, it is better to use morning bright light and perhaps a lower dose of melatonin.
登录
查看更多内容
影响因子:
2.2
作者:
AKERSTEDT, T;GILLBERG, M
通讯作者:
GILLBERG, M
DOI:
10.3758/bf03200977
发表时间:
1985-12-01
期刊:
BEHAVIOR RESEARCH METHODS INSTRUMENTS & COMPUTERS
影响因子:
--
作者:
DINGES, DF;POWELL, JW
通讯作者:
POWELL, JW
影响因子:
2.5
作者:
DEACON, S;ENGLISH, J;ARENDT, J
通讯作者:
ARENDT, J
影响因子:
2.9
作者:
DEACON, S;ARENDT, J
通讯作者:
ARENDT, J
影响因子:
2.8
作者:
Eastman CI;Molina TA;Dziepak ME;Smith MR
通讯作者:
Smith MR